Fulgent Genetics Inc
NASDAQ:FLGT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
US |
Balance Sheet
Balance Sheet Decomposition
Fulgent Genetics Inc
Fulgent Genetics Inc
Balance Sheet
Fulgent Genetics Inc
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
8
|
7
|
7
|
12
|
87
|
165
|
80
|
97
|
55
|
50
|
|
| Cash Equivalents |
0
|
1
|
8
|
7
|
7
|
12
|
87
|
165
|
80
|
97
|
55
|
50
|
|
| Short-Term Investments |
0
|
0
|
13
|
20
|
24
|
16
|
212
|
286
|
447
|
327
|
203
|
286
|
|
| Total Receivables |
0
|
2
|
5
|
6
|
8
|
7
|
204
|
145
|
91
|
57
|
77
|
92
|
|
| Accounts Receivables |
0
|
2
|
5
|
4
|
6
|
7
|
185
|
139
|
53
|
51
|
69
|
85
|
|
| Other Receivables |
0
|
0
|
0
|
2
|
2
|
1
|
19
|
6
|
38
|
6
|
8
|
7
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
2
|
20
|
16
|
11
|
26
|
18
|
123
|
|
| Total Current Assets |
1
|
3
|
26
|
33
|
40
|
37
|
524
|
612
|
628
|
508
|
354
|
550
|
|
| PP&E Net |
1
|
3
|
6
|
7
|
6
|
9
|
41
|
71
|
99
|
96
|
112
|
118
|
|
| PP&E Gross |
1
|
3
|
6
|
7
|
6
|
9
|
41
|
71
|
99
|
96
|
112
|
118
|
|
| Accumulated Depreciation |
0
|
1
|
2
|
4
|
6
|
8
|
11
|
20
|
43
|
52
|
52
|
58
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
36
|
151
|
143
|
135
|
133
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
143
|
22
|
22
|
25
|
|
| Long-Term Investments |
0
|
0
|
26
|
17
|
8
|
43
|
133
|
485
|
327
|
424
|
570
|
369
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
24
|
39
|
43
|
27
|
18
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
143
|
22
|
22
|
25
|
|
| Total Assets |
2
N/A
|
6
+176%
|
58
+900%
|
57
-1%
|
54
-6%
|
89
+65%
|
701
+689%
|
1 279
+83%
|
1 386
+8%
|
1 235
-11%
|
1 220
-1%
|
1 214
-1%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
0
|
3
|
2
|
1
|
2
|
27
|
21
|
23
|
15
|
18
|
19
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
9
|
18
|
25
|
30
|
24
|
34
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
15
|
21
|
21
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
80
|
46
|
19
|
26
|
30
|
32
|
|
| Total Current Liabilities |
0
|
1
|
3
|
3
|
3
|
4
|
130
|
105
|
88
|
73
|
73
|
85
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
3
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
14
|
11
|
14
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
3
|
3
|
4
|
5
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
5
|
16
|
11
|
4
|
6
|
|
| Total Liabilities |
0
N/A
|
1
+75%
|
4
+414%
|
3
-17%
|
3
-7%
|
6
+114%
|
131
+2 085%
|
120
-8%
|
119
-1%
|
99
-17%
|
87
-13%
|
102
+17%
|
|
| Equity | |||||||||||||
| Common Stock |
12
|
58
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
53
|
55
|
58
|
63
|
63
|
151
|
658
|
801
|
633
|
590
|
530
|
|
| Additional Paid In Capital |
0
|
0
|
110
|
112
|
114
|
146
|
418
|
502
|
487
|
502
|
543
|
575
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
21
|
1
|
0
|
8
|
|
| Total Equity |
2
N/A
|
5
+200%
|
55
+969%
|
54
-1%
|
51
-6%
|
83
+62%
|
569
+588%
|
1 159
+103%
|
1 267
+9%
|
1 136
-10%
|
1 133
0%
|
1 112
-2%
|
|
| Total Liabilities & Equity |
2
N/A
|
6
+176%
|
58
+900%
|
57
-1%
|
54
-6%
|
89
+65%
|
701
+689%
|
1 279
+83%
|
1 386
+8%
|
1 235
-11%
|
1 220
-1%
|
1 214
-1%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
17
|
17
|
18
|
18
|
18
|
22
|
28
|
30
|
29
|
30
|
31
|
31
|
|